Announcements
- COSMO ANNOUNCES FULL-YEAR RESULTS 2021; CONFIRMS BEATING GUIDANCE
- First U.S. trial using GI Genius(TM) intelligent endoscopy module shows 50% reduction in missed colorectal polyps with Artificial Intelligence (AI) technology versus standard colonoscopy
- Invitation to Cosmo's full-year 2021 results and 2022 outlook webcast presentation on 23 March 2022
Key statistics
As of last trade Cosmo Pharmaceuticals NV (CMOPF:PKL) traded at 47.50, 0.00% above its 52-week low of 47.50, set on May 09, 2022.
52-week range
Markit short selling activity
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 47.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 17.54m |
Free float | 10.09m |
P/E (TTM) | 49.04 |
Market cap | 894.92m CHF |
EPS (TTM) | 1.04 CHF |
Data delayed at least 15 minutes, as of May 09 2022.
More ▼